secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspira Women's Health Inc. (AWHL)
CIK:        0000926617
Form:       8-K
Filed at:   2022-12-02T23:59:59+00:00
Accession:  0000926617-22-000064
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspira Women's Health gets 180-day Nasdaq extension to May 2023 to cure $1 bid price deficiency
--------------------------------------------------------------------------------

- Received Nasdaq notice granting 180-day extension until May 29, 2023, to meet minimum $1.00 bid price requirement.
- Initial cure period ended Nov 28, 2022, without compliance; extension granted due to intent to effect a reverse stock split.
- If not compliant by May 29, 2023, Nasdaq will delist; company may appeal to a hearing panel.
- Company must achieve closing bid price of $1.00 for 10 consecutive business days to regain compliance.
- Common stock listed on Nasdaq under symbol AWH.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/926617/000092661722000064/0000926617-22-000064-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/926617/000092661722000064/awh-20221129x8k.htm
  HTML page:      https://secwatch.observer/filing/0000926617-22-000064

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer